Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 33.71M 39.34M 31.59M 28.85M 54.45M 3.75B 54.99M 373M 145M 1.89B 148M 144M 6.27B | P/E 2026 * |
-5.46x | P/E 2027 * | 38.3x |
|---|---|---|---|---|---|
| Enterprise Value | 33.71M 39.34M 31.59M 28.85M 54.45M 3.75B 54.99M 373M 145M 1.89B 148M 144M 6.27B | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | 3.37x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 39.33M | |
| +3.76% | +15.73% | +83.37% | +41.94% | 372B | |
| +0.69% | +1.90% | +26.68% | -13.07% | 70.21B | |
| +0.38% | +4.21% | +51.37% | +156.04% | 12.33B | |
| -0.50% | +0.96% | -2.77% | -1.31% | 8.49B | |
| -2.31% | -3.32% | -14.66% | -1.06% | 4.89B | |
| -1.19% | -0.48% | -27.57% | +15.69% | 4.54B | |
| +1.34% | -29.39% | -24.38% | +6.91% | 3.04B | |
| +0.23% | -7.73% | +1.82% | +44.12% | 2.62B | |
| +2.75% | -3.82% | -14.32% | -6.50% | 2.05B | |
| Average | -0.27% | +1.23% | +8.84% | +26.98% | 53.32B | |
| Weighted average by Cap. | +2.98% | +8.71% | +69.13% | +34.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.5M 2.81M 2.57M 4.85M 334M 4.89M 33.16M 12.91M 168M 13.15M 12.86M 558M | 10M 11.67M 9.37M 8.56M 16.15M 1.11B 16.31M 111M 43.03M 561M 43.82M 42.86M 1.86B |
| Net income | -6M -7M -5.62M -5.14M -9.69M -668M -9.79M -66.32M -25.82M -337M -26.29M -25.72M -1.12B | 1M 1.17M 937K 856K 1.62M 111M 1.63M 11.05M 4.3M 56.13M 4.38M 4.29M 186M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
